Henry S. Friedman, MD, is Professor of Neuro-Oncology at Duke University Medical Center. He is an internationally recognized neuro-oncologist with a career-long interest in the treatment of children and adults with brain and spinal cord tumors. He has written hundreds of articles on both the clinical and laboratory investigation of these neoplasms.
Areas of expertise:
Adults and children with primary and secondary brain and spinal-cord tumors; laboratory and clinical design of new therapeutic strategies utilizing alkylating agents, monoclonal antibodies, small-molecule inhibitors, gene therapy, vaccines and other approaches.
Biology and therapy of adult and childhood central nervous system malignancies, particularly high-grade medulloblastoma, glioma, and ependymoma.